We are live on ! Find out more
GBT

Global Blood Therapeutics, Inc.
GBT

Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

84 hedge funds and large institutions have $488M invested in Global Blood Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 19 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 19

26% more capital invested

Capital invested by funds: $389M → $488M (+$99.9M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

10% less funds holding

Funds holding: 93 → 84 (-9)

11% less call options, than puts

Call options by funds: $5.29M | Put options by funds: $5.97M

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

Holders
84
Holders Change
-9
Holders Change %
-9.68%
% of All Funds
2.24%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
15
Increased
38
Reduced
19
Closed
24
Calls
$5.29M
Puts
$5.97M
Net Calls
-$679K
Net Calls Change
-$1.33M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$10.4M
2
IHM
Iguana Healthcare Management
New York
+$6.67M
3
DCM
Driehaus Capital Management
Illinois
+$4.37M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.73M
5
BIT
BlackRock Institutional Trust
California
+$3.28M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$29.8M
2
PHS
PFM Health Sciences
California
-$17.1M
3
SM
Sabby Management
Florida
-$4.84M
4
FCMI
Foresite Capital Management III
California
-$4.47M
5
Jennison Associates
Jennison Associates
New York
-$3.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$2.33M +$1.93M +101,200 New
AG
27
Artal Group
Luxembourg
$2.31M -$476K -25,000 -20%
RSCM
28
Rock Springs Capital Management
Maryland
$2.26M – – –
RI
29
RTW Investments
New York
$2.21M -$27.1K -1,424 -1%
CCM
30
Century Capital Management
Massachusetts
$2.19M +$1.81M +95,041 New
BIM
31
BlackRock Investment Management
Delaware
$1.95M +$273K +14,321 +20%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$1.9M +$1.27M +66,874 +431%
Deutsche Bank
33
Deutsche Bank
Germany
$1.76M +$947K +49,668 +186%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.64M +$541K +28,375 +66%
FMBTD
35
First Midwest Bank Trust Division
Illinois
$1.59M +$1.31M +68,825 New
SIM
36
Spark Investment Management
New York
$1.48M -$1.71M -89,600 -58%
Charles Schwab
37
Charles Schwab
California
$1.45M +$580K +30,436 +94%
CS
38
Candriam SCA
Luxembourg
$1.38M +$476K +25,000 +71%
Thrivent Financial for Lutherans
39
Thrivent Financial for Lutherans
Minnesota
$1.19M – – –
DCM
40
Dialectic Capital Management
Connecticut
$1.18M +$591K +31,000 +155%
BlackRock
41
BlackRock
New York
$1.15M +$14.8K +775 +2%
Norges Bank
42
Norges Bank
Norway
$1.07M -$217K -11,400 -19%
FIM
43
Fernwood Investment Management
Massachusetts
$922K +$1.91K +100 +0.3%
OAM
44
Oxford Asset Management
United Kingdom
$891K +$737K +38,645 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$807K +$105K +5,500 +19%
MC
46
Marcus Capital
Illinois
$694K – – –
AllianceBernstein
47
AllianceBernstein
Tennessee
$657K +$56.3K +2,954 +12%
Swiss National Bank
48
Swiss National Bank
Switzerland
$648K – – –
Citadel Advisors
49
Citadel Advisors
Florida
$648K +$536K +28,127 New
Morgan Stanley
50
Morgan Stanley
New York
$631K -$867K -45,482 -62%
1
2
3 4 5

GBT Hedge Fund Activity: Q3 2016 in Review

84 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Global Blood Therapeutics, Inc. (GBT) for Q3 2016, worth a combined $488M — up 26% from $389M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of GBT and 15 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 38 added.

The largest buyer was Wellington Management Group, adding an estimated $10.4M. The largest seller was Deerfield Management, cutting an estimated $29.8M.

  • 84 institutional investors held Global Blood Therapeutics, Inc. (GBT) as of Q3 2016, down from 93 in Q2 2016.
  • Funds reported $488M of Global Blood Therapeutics, Inc. stock for Q3 2016, up 26% quarter-over-quarter.
  • 15 funds opened new Global Blood Therapeutics, Inc. positions in Q3 2016 and 24 closed out, a net change of -9 holders.
  • The largest Global Blood Therapeutics, Inc. buyer in Q3 2016 was Wellington Management Group, an estimated $10.4M added.
  • The largest Global Blood Therapeutics, Inc. seller in Q3 2016 was Deerfield Management, an estimated $29.8M sold.

Based on aggregated 13F filings for Q3 2016.